ASIA-PACIFIC EPILEPSY DEVICES MARKET FORECAST 2022-2030

 

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES

1.2. SCOPE OF STUDY

1.3. METHODOLOGY

1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES

2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS

3.1.1. SOARING OCCURRENCES OF EPILEPSY GLOBALLY

3.1.2. ONSET OF EPILEPSY IN ELDERLY PEOPLE

3.1.3. MITIGATION OF EPILEPSY USING EARLY DIAGNOSIS

3.1.4. SURGE IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES

3.2. KEY RESTRAINTS

3.2.1. MISPERCEPTIONS AND MISINFORMATION ABOUT EPILEPSY

3.2.2. SHORTAGE OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON EPILEPSY DEVICES MARKET

4.2. KEY MARKET TRENDS

4.3. PORTER’S FIVE FORCES ANALYSIS

4.3.1. BUYERS POWER

4.3.2. SUPPLIERS POWER

4.3.3. SUBSTITUTION

4.3.4. NEW ENTRANTS

4.3.5. INDUSTRY RIVALRY

4.4. OPPORTUNITY MATRIX

4.5. VENDOR LANDSCAPE

4.6. VALUE CHAIN ANALYSIS

4.7. KEY BUYING CRITERIA

4.7.1. COMFORT & USABILITY

4.7.2. PRODUCT FEATURES

4.7.3. CONFIDENTIALITY

4.8. REGULATORY FRAMEWORK

5. MARKET BY PRODUCT TYPE

5.1. CONVENTIONAL DEVICES

5.2. WEARABLE DEVICES

5.2.1. WATCHES

5.2.2. BRACELETS

5.2.3. CAMERA DEVICES

5.2.4. MATTRESS DEVICES

5.2.5. ANTI-SUFFOCATION PILLOWS

5.2.6. OTHER WEARABLE DEVICES

5.3. IMPLANTABLE DEVICES

6. MARKET BY TECHNOLOGY

6.1. VAGUS NERVE STIMULATION

6.2. DEEP BRAIN STIMULATION

6.2.1. MOVEMENT DISORDERS

6.2.2. EPILEPSY

6.3. ACCELEROMETRY

6.4. RESPONSIVE NEUROSTIMULATION

7. MARKET BY DETECTION & PREDICTION DEVICES TYPE

7.1. ELECTROENCEPHALOGRAM

7.2. INTRACRANIAL EEG

7.3. SURFACE ELECTROMYOGRAPHY

7.4. ELECTROCARDIOGRAPHY

7.5. VIDEO DETECTION SYSTEMS

7.6. ELECTRODERMAL ACTIVITY

7.7. IMPLANTED ADVISORY SYSTEMS

7.8. OTHER DETECTION & PREDICTION DEVICE TYPES

8. MARKET BY END-USER

8.1. HOSPITALS & CLINICS

8.2. NEUROLOGY CENTERS

8.3. HOME CARE SETTINGS

8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

9.1. ASIA-PACIFIC

9.1.1. MARKET ESTIMATES & SIZES

9.1.2. KEY GROWTH ENABLERS

9.1.3. KEY CHALLENGES

9.1.4. KEY PLAYERS

9.1.5. COUNTRY ANALYSIS

9.1.5.1. CHINA

9.1.5.2. JAPAN

9.1.5.3. INDIA

9.1.5.4. SOUTH KOREA

9.1.5.5. INDONESIA

9.1.5.6. SINGAPORE

9.1.5.7. TAIWAN

9.1.5.8. AUSTRALIA & NEW ZEALAND

9.1.5.9. REST OF ASIA-PACIFIC

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS

10.1.1. ACQUISITIONS

10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS

10.1.3. PARTNERSHIPS

10.2. COMPANY PROFILES

10.2.1. BOSTON SCIENTIFIC CORPORATION

10.2.2. CADWELL INDUSTRIES INC

10.2.3. COMPUMEDICS LIMITED

10.2.4. DRÄGERWERK AG & CO KGAA

10.2.5. EMPATICA INC

10.2.6. KONINKLIJKE PHILIPS NV

10.2.7. LIVANOVA PLC

10.2.8. MEDTRONIC PLC

10.2.9. NATUS MEDICAL INCORPORATED

10.2.10. NEUROPACE INC

10.2.11. NEUROSOFT

10.2.12. NIHON KOHDEN CORPORATION

10.2.13. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD

 

LIST OF TABLES

TABLE 1: ASIA-PACIFIC MARKET SNAPSHOT – EPILEPSY DEVICES

TABLE 2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES

TABLE 3: EXAMPLES OF MOBILE EEG DEVICES

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: LEADING PLAYERS OPERATING IN ASIA-PACIFIC EPILEPSY DEVICES MARKET

TABLE 20: LIST OF ACQUISITIONS

TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 22: LIST OF PARTNERSHIPS

 

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

FIGURE 8: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021

FIGURE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 19: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION, IN 2021

FIGURE 22: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)

FIGURE 25: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 26: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION & PREDICTION DEVICES TYPE, IN 2021

FIGURE 27: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)

FIGURE 29: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 30: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 31: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $ MILLION)

FIGURE 32: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $ MILLION)

FIGURE 33: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $ MILLION)

FIGURE 34: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICE TYPES, 2022-2030 (IN $ MILLION)

FIGURE 35: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 36: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)

FIGURE 37: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)

FIGURE 38: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ MILLION)

FIGURE 39: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

FIGURE 40: ASIA-PACIFIC EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)

FIGURE 41: CHINA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: JAPAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: INDIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: SOUTH KOREA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: INDONESIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: SINGAPORE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: TAIWAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 48: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

 

KEY FINDINGS

The Asia-Pacific epilepsy devices market is set to record an 8.05% CAGR during the forecast period, 2022-2030. Attractive training and research opportunities provided by key market players, the high prevalence of epilepsy, and the rising presence of the geriatric population in the region propel market growth.

 

Get more Insights into the Asia-Pacific Epilepsy Devices Market:

https://inkwoodresearch.com/reports/asia-pacific-epilepsy-devices-market/

 

MARKET INSIGHTS

The Asia-Pacific epilepsy devices market growth evaluation covers a detailed study of South Korea, China, Singapore, Taiwan, India, Indonesia, Japan, Australia & New Zealand, and Rest of Asia-Pacific. According to our study, there has been a rising prevalence of epilepsy in South Korea. The population’s aging is the primary cause of this rapid surge. In addition, South Korea also witnessed an increase in cases of epilepsy among elderly persons. Also, thousands of epilepsy incidences in the first year of life and early childhood also drive the demand for epilepsy devices in the country.

On the other hand, despite contemporary antiepileptic medicines (AEDs), up to 30-40% of epilepsy patients in Indonesia still experience seizures, and almost half of these could benefit from surgery. As a result, wearable and implantable gadgets will become more popular in the area during the predicted period. The greatest imaging technique available nationwide for patients with partial epilepsy is magnetic resonance imaging (MRI). While many clinics are still in the planning stage, some programs offer exceptional care for people with epilepsy.

In Singapore, recent developments in neuroimaging have drawn interest due to their potential to both improve our understanding of epileptogenic lesions and reveal new information about the pathophysiology of epilepsy. The study market in Singapore will continue to grow due to the rising number of clinical and experimental applications of machine learning and network analysis in epilepsy. The nation also has the greatest percentage of epilepsy surgical use, which raises the demand for epilepsy gadgets.

 

COMPETITIVE INSIGHTS

Some of the key players in the market are Koninklijke Philips NV, Nihon Kohden Corporation, etc.

 

Our report offerings include:

·       Explore key findings of the overall market

·       Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

·       Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

·       Market Segmentation caters to a thorough assessment of key segments with their market estimations

·       Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

·       Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

·       Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

·       Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

 

SEGMENTATION

1.     BOSTON SCIENTIFIC CORPORATION

2.     CADWELL INDUSTRIES INC

3.     COMPUMEDICS LIMITED

4.     DRÄGERWERK AG & CO KGAA

5.     EMPATICA INC

6.     KONINKLIJKE PHILIPS NV

7.     LIVANOVA PLC

8.     MEDTRONIC PLC

9.     NATUS MEDICAL INCORPORATED

10. NEUROPACE INC

11. NEUROSOFT

12. NIHON KOHDEN CORPORATION

13. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD